Mitsubishi Pharma Corp., the product of an Oct. 1, 2001 merger of two pharmaceutical companies, said Monday it will launch an early retirement program for employees 45 and older.
About 1,900 people will be eligible for the program, it said.
Mitsubishi Pharma said it will accept applications for the program through Aug. 31 and pay extra retirement allowances for those who retire as of Sept. 30 under the program.
Mitsubishi Pharma was created through the merger between Welfide Corp. and Mitsubishi-Tokyo Pharmaceuticals Inc. last October.
It said it will announce how the retirement program will affect its earnings for the current business year to next March 31 after the number of applicants and the sum of extra retirement allowances are determined.